Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL

• Published in: The Journal of immunology (1950) Vol. 150; no. 7; pp. 2794 - 2804
• Main Authors: Cogswell, PC, Scheinman, RI, Baldwin, AS, Jr
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Am Assoc Immnol 01.04.1993; American Association of Immunologists
• Subjects: Base Sequence; Biological and medical sciences; Cloning, Molecular; Drug Synergism; Fundamental and applied biological sciences. Psychology; Gene Expression Regulation; Genes. Genome; Humans; Molecular and cellular biology; Molecular genetics; Molecular Sequence Data; NF-kappa B - biosynthesis; NF-kappa B - genetics; NF-kappa B - physiology; NF-kappa B p50 Subunit; Promoter Regions, Genetic; Protein Binding; Protein Precursors - biosynthesis; Protein Precursors - genetics; Protein Precursors - physiology; Proto-Oncogene Proteins - physiology; Proto-Oncogene Proteins c-rel; Transcription, Genetic; Human; Immunogenetics; Regulation(control); Gene; Nucleotide sequence; Transcription; Transcription promoter; Binding site; Gene expression; Transcription initiation
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.150.7.2794

NF-kappa B is a transcription factor involved in the regulation of numerous genes encoding proteins involved in immune function, in inflammation or in cellular growth control. NF-kappa B is typically characterized as a heterodimer of a 50-kDa subunit (p50) and a 65-kDa (p65) subunit. Interestingly, the p50 subunit is derived by processing of a 105-kDa precursor. Induction of NF-kappa B DNA-binding activity involves both the release of cytoplasmically stored factor from its inhibitor known as I kappa B and the induction of NF-kappa B gene expression. We report here the cloning and functional analysis of the promoter of the p50/p105 NF-kappa B gene. Our data suggest the existence of multiple transcription initiation sites for this gene in the B cell line Raji, Jurkat T cells, and HeLa cells. The promoter is constitutively active in these cells and is inducible by phorbol ester and mitogen stimulation of Jurkat T cells. Expression of I kappa B inhibits this inducible activation of the p50/p105 promoter. Furthermore, we have shown that co-transfection of a p50/p105 promoter-reporter plasmid with expression vectors encoding the p50 or p65 subunits of NF-kappa B or c-Rel results in stimulation of gene expression. Supportive of the transfection data, we have identified a DNA-binding site for NF-kappa B in the promoter of the p50/p105 gene that is responsive only to a combination of p50 and p65. The data demonstrate that the p50/p105 NF-kappa B gene is regulated by members of the NF-kappa B/Rel family and likely by other important transcription factors.